Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other Accumulated Expenses (2016 - 2017)

Wave Life Sciences (WVE) has disclosed Other Accumulated Expenses for 3 consecutive years, with $156000.0 as the latest value for Q4 2017.

  • For the quarter ending Q4 2017, Other Accumulated Expenses fell 83.54% year-over-year to $156000.0, compared with a TTM value of $156000.0 through Dec 2017, down 83.54%, and an annual FY2017 reading of $156000.0, down 83.54% over the prior year.
  • Other Accumulated Expenses was $156000.0 for Q4 2017 at Wave Life Sciences, down from $948000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $948000.0 in Q4 2016 and bottomed at $156000.0 in Q4 2017.
  • Average Other Accumulated Expenses over 3 years is $465750.0, with a median of $379500.0 recorded in 2015.
  • The sharpest move saw Other Accumulated Expenses skyrocketed 168.56% in 2016, then tumbled 83.54% in 2017.
  • Year by year, Other Accumulated Expenses stood at $353000.0 in 2015, then surged by 168.56% to $948000.0 in 2016, then crashed by 83.54% to $156000.0 in 2017.
  • Business Quant data shows Other Accumulated Expenses for WVE at $156000.0 in Q4 2017, $948000.0 in Q4 2016, and $353000.0 in Q4 2015.